Sign inJoin waitlistJoin the waitlist

Maria Sullivan

Associate Professor of Clinical Psychiatry · New York Presbyterian Hospital

Credentials: · · ·

History

New York Presbyterian Hospital
Present

New York State Psychiatric Institute
1996–1997
New York Presbyterian Hospital
1992–1996
George Washington Univ Sch of Med

Research

Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial
Archives of General Psychiatry · 2006 · 271 citations
A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease
American Journal of Psychiatry · 1998 · 168 citations
Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers
Neuropsychopharmacology · 2008 · 128 citations

Adam Bisaga
31 papers
Edward Nunes
31 papers
Frances Levin
19 papers
Jeanne Manubay
14 papers
John Mariani
13 papers
SA
Sarah Akerman
13 papers
AZ
Abigail Zavod
6 papers
Herbert Kleber
6 papers
SM
Shanthi Mogali
6 papers
WR
Wilfrid Raby
6 papers
Paolo Mannelli
5 papers
David Mysels
4 papers · 4 as a resident

Grants

Improved Strategies for Outpatient Opioid Detoxification
National Institute on Drug Abuse · R01
Contact PI · $1.9M · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
2011–2016
Predictors of Relapse to Prescription Opioid Abuse Among Pain Patients
National Institute on Drug Abuse · R01
Contact PI · $2.5M · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
2005–2012
Opiate Dependence: Combined Naltrexone/Behavior Therapy
National Institute on Drug Abuse · R01
Contact PI · $859.9K · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
1997–2010
Opiate and Nicotine Dependence--Medications and Therapy
National Institute on Drug Abuse · K23
Contact PI · $819.3K · Columbia University Health Sciences
1999–2006

Clinical trials

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone
Principal investigator · Completed · Phase 3
New York State Psychiatric Institute
2007–2011
Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse
Principal investigator · Completed · Phase 2
New York State Psychiatric Institute
2005–2011
Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL
Study director · Completed · Phase 3
Alkermes, Inc.
2016–2017
Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)
Study director · Completed · Phase 3
Alkermes, Inc.
2015–2017